Targeting MnSOD or mROS with redox-active drugs could facilitate the engulfment of cancer cells by M1 macrophages and inhibit M2 macrophage functions, EMT progression, cancer stemness, and tumor advancement. Here, SOD2 is linked to neoplasm.